Though I do understand the importance of hearing the FDA have approved the IND application for HemaXellerate, that is not the most important factor. Perhaps in the short term. But there are a number of things that are playing a significant role in making this company a long-time sparkle in many deep pockets eyes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.